SCHEMBL23893552

SCHEMBL23893552

CCc1ccccc1-c1cc2ccc(OC(C)(C)CC(C)(C)O)cc2o1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTPN1 P18031 1/20 0.38
▸ RAB9A P51151 7/20 0.37
▸ ALDH1A1 P00352 5/20 0.37
▸ SMN1; SMN2 Q16637 3/20 0.37
▸ NPC1 O15118 6/20 0.37
▸ KDM4E B2RXH2 5/20 0.37
▸ KMT2A Q03164 4/20 0.37
▸ GLA P06280 3/20 0.37
▸ MEN1 O00255 2/20 0.37
▸ HDAC6 Q9UBN7 1/20 0.35
▸ SRD5A1 P18405 2/20 0.35
▸ SRD5A2 P31213 1/20 0.35
▸ GPR55 Q9Y2T6 1/20 0.35
▸ APP P05067 1/20 0.35
▸ MAOB P27338 2/20 0.35
▸ HPGD P15428 3/20 0.34
▸ GAA P10253 2/20 0.34
▸ POLB P06746 1/20 0.34
▸ CA12 O43570 1/20 0.34
▸ CA2 P00918 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23893401 0.86 SRD5A1 (0.35) PTPN1RAB9AALDH1A1SMN1; SMN2NPC1
SCHEMBL22595318 0.84 CYP3A4 (0.37) PTPN1RAB9AALDH1A1SMN1; SMN2NPC1
SCHEMBL23395673 0.83 HIF1A (0.44) RAB9AALDH1A1SMN1; SMN2NPC1KDM4E
SCHEMBL23395722 0.83 ALDH1A1 (0.36) PTPN1RAB9AALDH1A1SMN1; SMN2NPC1
SCHEMBL25900896 0.82 HDAC6 (0.37) PTPN1RAB9ASMN1; SMN2NPC1KMT2A
SCHEMBL23395724 0.82 ALDH1A1 (0.42) PTPN1ALDH1A1SRD5A1SRD5A2HIF1A
SCHEMBL23395670 0.81 KLK7 (0.39) PTPN1RAB9AALDH1A1SMN1; SMN2NPC1
SCHEMBL23395611 0.81 KDM4E (0.37) RAB9AALDH1A1SMN1; SMN2NPC1KDM4E
SCHEMBL23893581 0.81 RAB9A (0.34) PTPN1RAB9AALDH1A1SMN1; SMN2NPC1
SCHEMBL30568050 0.80 PTPN1 (0.53) PTPN1RAB9AALDH1A1NPC1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11753387-B2 Compounds for optically active devices Johnson & Johnson Surgical Vision, Inc. (US) 2023-09-12 — — US disclosed
EP-3889135-B1 COMPOUNDS FOR OPTICALLY ACTIVE DEVICES AMO Ireland (IE) 2023-08-02 — — EP disclosed
EP-3889135-A1 COMPOUNDS FOR OPTICALLY ACTIVE DEVICES Merck Patent GmbH (DE) 2021-10-06 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11753387-B2 Compounds for optically active devices PDE6C, PDE6A, PDE6D PTPN1 4651/4885RAB9A 1119/4885ALDH1A1 388/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback